Molecular, Epigenetic, and Immune Landscape of TP53-mutated (TP53-M) Acute Myeloid Leukemia (AML) and Higher Risk Myelodysplastic Syndromes (HR-MDS)
- Resource Type
- Abstract
- Source
- In
Blood 15 November 2022 140 Supplement 1:6247-6249 - Subject
- Language
- ISSN
- 0006-4971